RecruitingNCT07433660

WellSpan-THRIVE Cancer QOL Study

WellSpan Study of Tracking Health and Resilience to Improve the Vitality of Individuals Experiencing Cancer [WellSpan-THRIVE]


Sponsor

WellSpan Health

Enrollment

1,000 participants

Start Date

Feb 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences. This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age 18 years and above
  • Primary cancer diagnosis (newly diagnosed within the past 6 months)
  • Able to sign informed consent.

Exclusion Criteria4

  • Patients with age\<18 years,
  • Patients with primary non-melanoma skin, neurological malignancies (Brain or brain metastases), and primary hematological malignancies.
  • Patients with severe cognitive impairment, unable to sign informed consent or unable to complete quality of life questionnaire.
  • Patients with life expectancy of \<90 days, in the opinion of treating investigator.

Locations(5)

WellSpan Medical Oncology & Hematology

Chambersburg, Pennsylvania, United States

WellSpan Ephrata Cancer Center

Ephrata, Pennsylvania, United States

WellSpan Adams Cancer Center

Gettysburg, Pennsylvania, United States

WellSpan Sechler Family Cancer Center

Lebanon, Pennsylvania, United States

WellSpan York Cancer Center

York, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07433660


Related Trials